Hypercholesterolemia and inflammation in atherogenesis: two sides of the same coin.

作者: Daniel Steinberg

DOI: 10.1002/MNFR.200500081

关键词:

摘要: An abundance of experimental, clinical, and epidemiologic data capped by stunning interventional results with the statins has established hypercholesterolemia as a major causative factor in atherogenesis. In familial animal models it is sufficient cause. Some degree hypercholesterolemia, perhaps 30–50 mg/dL, may even be necessary It equally clear that from very beginning atherogenesis strong inflammatory component, i. e., characterized penetration monocytes T-cells into developing lesion. These cells, through secretion cytokines growth factors, immune responses, complex cross-talk elements artery wall modulate lesion affect its stability. But inflammation to occur response something. What something? “injury” “response-to-injury”? The case will made oxidized lipids LDL or generated prooxidative changes cells should considered plausible candidate. There no need consider alternative hypotheses. Both are much involved. Optimal intervention prevention probably require attention both.

参考文章(29)
Scott M Grundy, James I Cleeman, C Noel Bairey Merz, H Bryan Brewer Jr, Luther T Clark, Donald B Hunninghake, Richard C Pasternak, Sidney C Smith Jr, Neil J Stone, None, Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Circulation. ,vol. 44, pp. 227- 239 ,(2004) , 10.1161/01.CIR.0000133317.49796.0E
Goran K Hansson, None, Immune mechanisms in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 21, pp. 1876- 1890 ,(1989) , 10.1161/HQ1201.100220
Russell Ross, The pathogenesis of atherosclerosis: a perspective for the 1990s Nature. ,vol. 362, pp. 801- 809 ,(1993) , 10.1038/362801A0
John C LaRosa, Scott M Grundy, David D Waters, Charles Shear, Philip Barter, Jean-Charles Fruchart, Antonio M Gotto, Heiner Greten, John JP Kastelein, James Shepherd, Nanette K Wenger, None, Intensive lipid lowering with atorvastatin in patients with stable coronary disease. The New England Journal of Medicine. ,vol. 352, pp. 1425- 1435 ,(2005) , 10.1056/NEJMOA050461
H C Stary, A B Chandler, S Glagov, J R Guyton, W Insull, M E Rosenfeld, S A Schaffer, C J Schwartz, W D Wagner, R W Wissler, A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 14, pp. 840- 856 ,(1994) , 10.1161/01.ATV.14.5.840
Henry C. McGill, C. Alex McMahan, Gray T. Malcom, Margaret C. Oalmann, Jack P. Strong, Effects of Serum Lipoproteins and Smoking on Atherosclerosis in Young Men and Women Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 17, pp. 95- 106 ,(1997) , 10.1161/01.ATV.17.1.95
M S Brown, J L Goldstein, Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis Annual Review of Biochemistry. ,vol. 52, pp. 223- 261 ,(1983) , 10.1146/ANNUREV.BI.52.070183.001255
Russell Ross, Atherosclerosis — An Inflammatory Disease The New England Journal of Medicine. ,vol. 340, pp. 115- 126 ,(1999) , 10.1056/NEJM199901143400207